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Abstract This study is aimed to investigate the differentially
expressed long non-coding RNAs (lncRNAs) in colorectal
cancer and its potential biological function. Colorectal adeno-
ma is the precancerous lesions of colorectal cancer, so in this
study, we used colorectal adenoma as negative control. The
global lncRNA expression profile in colorectal cancer and
adenoma was evaluated by bioinformatics. The biological
functions and potential mechanism of AK027294 were inves-
tigated in HCT116, HCT8, and SW480 colorectal cancer cells.
A total of 135 lncRNAs were found to be differentially
expressed in colorectal cancer and adenoma tissues. Among
them, 71 lncRNAs were up-regulated and 64 lncRNAs were
down-regulated. Especially, AK027294 was found to be high-
ly expressed in colorectal cancer tissues compared with colo-
rectal adenoma tissues (fold change is 184.5). Our results
indicated that AK027294 down-regulation significantly
inhibited colorectal cancer cells proliferation and migration,
but promoted cell apoptosis (P<0.05). The potential mecha-
nism of AK027294 might be associated with the regulation of
caspase-3, caspase-8, Bcl-2, MMP12, MMP9, and TWIST.
The lncRNA expression profile in colorectal cancer suggests
lncRNAs may play important roles in the occurrence and pro-
gression of colorectal cancer. AK027294 is highly expressed
in colorectal cancer and closely correlates with colorectal cells
proliferation, migration, and apoptosis.
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Introduction
Colorectal cancer (CRC) is the third most common cancer in
the world, with an estimated incidence of more than one mil-
lion case [1, 2]. Although the long-term survival rates for
patients with early CRC have been improved based on the
improvement of diagnosis and treatment, the prognosis of
patients with advanced disease remains unsatisfied [3]. There-
fore, some specific biomarkers associated with CRC will be
potentially helpful for the prognosis of these patients.
Long non-coding RNAs (lncRNAs), sized from 200 nt to
100 kb, is reported to be vital for governing fundamental bio-
logical processes, such as cell proliferation, cell migration, cell
cycle, and cell apoptosis [4–6]. However, primary studies re-
ported that lncRNAs were transcriptional Bnoise^ without bi-
ological functions [7, 8]. Recently, lncRNAs have been report-
ed to be associated with tumor formation and progression [9,
10]. For example, Chung et al. reported that prostate cancer
non-coding RNA 1 (PRNCR1) was involved in the occur-
rence of prostate cancer [11]. Gao et al. demonstrated that
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LncRNA-HOST2 played a key role in regulating cell biolog-
ical behaviors in ovarian cancer [12]. In colorectal cancer,
novel lncRNA RP11-462C24.1 was found to be lowly
expressed and correlated with patients’ prognosis [13]. More-
over, Han et al. screened lymph nodes metastasis associated
long noncoding RNAs (lncRNAs) by microarray analysis and
found that 545 lncRNAs were differentially expressed in met-
astatic lymph node in comparison with normal lymph node
(NLN) [14]. However, potential lncRNAs associated with co-
lorectal cancer has never been reported.
In this study, firstly we explored the differentially
expressed lncRNAs in colorectal cancer tissue compared with
colorectal adenoma tissues by using bioinformatics, then we
screened out the most differentially expressed lncRNAs with
biggest fold change. After this, we further detected the biolog-
ical functions and potential mechanism of the screen out
lncRNAs, for instance, the effects of the screen out lncRNAs
on the proliferation, migration and apoptosis of colorectal ad-
enoma cells. It may provide a promising target gene to prevent
the development and progression of colorectal cancer.
Materials and methods
Bioinformatics analysis
We obtained the GSE37364 microarray date from PUBMED
GEO Datasets (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE37364). GSE37360 microarray information:
total RNA was extracted from colonic biopsy samples of
histologically negative patients and of patients with adenoma
or colorectal cancer and were hybridized on Affymetrix
HGU133 Plus 2.0 microarrays. Then 5635 lncRNAs gene
expression data were obtained (Supplementary Data 1). The
whole genomic microarray analysis was performed in order to
identify gene expression profile alterations focusing on the
dysplastic adenoma-carcinoma transition. In this study, we
used this microarray data to screen out the differentially
expressed lncRNAs.
Patients information
In this study, three colorectal cancer tissues and one colorectal
adenoma tissue were obtained from Hai Nan Branch of PLA
General Hospital, and tqo colorectal adenoma tissues were
obtained from Hangzhou cancer hospital. Colorectal cancer
tissues were from two males and one female with mean age
of 54 years. Adenoma biopsy tissues were from twomales and
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Total RNAwas extracted from cultured HCT116 cells or pa-
tients’ adenoma and tumor tissues using TRIzol (Invitrogen
Life Technologies) and determined its concentration was de-
termined. Total RNA (0.5 μg) was used as a template to pre-
pare cDNA (Reverse Transcription System, Promega Corpo-
ration, Madison, WI, USA; cat. no. A3500). The messenger
RNA (mRNA) expression of target genes was quantified
using SYBR Premix EX Taq (Takara Bio, Inc., Shanghai,
China) on the ABI 7500 squence detection system (Advanced
Biosystem, Thermo Fisher Scientific, Waltham, MA, USA).
PCR was performed with the following thermocycling condi-
tions: an initial of 5 min at 95 °C, followed by 40 cycles of
95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s. The
thermocycler used in the present s tudy was the
StepOnePlus™ Real-Time PCR system (Applied Biosystems
Life Technologies, Foster City, CA, USA). All experiments
were performed in triplicate. Finally, the 2ΔΔCt method was
performed to calculate the relative expression. The primers
were obtained from Funengbio Co. (Shanghai, China). The
primer sequences are as follows.
Cell culture
RNA interference
HCT116 cells were transiently transfected with negative con-
trol small interfering RNA siRNA (200 nM, target gene:
caatgtatacattatggcag) and AK027294 siRNA (200 nM)
(siRNA1 target gene: caatggtgtggcctgattc; siRNA2 target gene:
agcagcttattctaccag; siRNA3 target gene: agacctgaatgacacctat),
respectively, using lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s instruc-
tions. These siRNAs were commercially synthesized by
Funengbio Co. (Shanghai, China). After incubated for 24 h,
cells were collected for follow experiments.
Wound healing assays
HCT116 cells were cultured in 6-well plates and transfected
with different oligonucleotides. When growing to about con-
fluent of 90 %, cells were scratched by a sterile 10 μl pipette
tip and incubated in a humidified incubator with 5 % CO2
atmosphere at 37 °C. Then the open wound area was mea-
sured at 0 and 24 h. The experiments were repeated for three
times.
Transwell invasion assay
After transfection at 24 h, cells (2×105) in 100 μl of serum-
free DMEM were cultured in 8-μm culture inserts. Then, the
lower chamber of the culture inserts was filled with 20 %
FBS-DMEM. Cells were cultured for 24 h, fixed with metha-
nol for 30 min, and stained with hematoxylin for 20 min.
Finally, migrated cells were counted in five random fields
under an inverted microscope (×20).
CCK-8 assay
About 2×103 cells were plated in 96-well plates. Cell prolif-
eration was evaluated using Cell Counting Kit-8 (KeyGEN
biotech, Nanjing, China) in accordance with the manufac-
turer’s instructions. The cell proliferation curves were plotted
by the absorbance values at different time point. All experi-
ments were performed for three times.
Western blotting
Total protein was collected using a lysis buffer and quan-
tified by bicinchoninic acid (BCA) method. Cell lysates
were separated using 10 % SDS-PAGE and transferred
to the polyvinylidene difluoride membrane. The mem-
branes were immersed into PBST solution supplemented
with 5 % non-fat milk for 2 h. Then, the membranes were
incubated with antibody-caspase 3 (dilution 1:200; Santa
Cruz, CA), antibody-caspase 8 (dilution 1:200; Santa
Cruz, CA), antibody-Bcl2 (dilution 1:200; Santa Cruz,
CA), antibody-TWIST1 (dilution 1:500; Santa Cruz, CA),
and antibody-GAPDH,(dilution 1:1000; Santa Cruz, CA),
respectively, at 4 °C overnight. All membranes were incu-
bated with appropriate second antibodyat room tempera-
ture for 1 h and visualized by enhanced chemilumines-
cence (PierceBiotechnology, Inc).
Apoptosis analysis by flow cytometry
Cells (1× 105) were collected by using Trypsin-EDTA and
washed with PBS. Then, cells were centrifugated and incubat-
ed with propidium iodide (PI; Sigma, USA) and annexin V-
FITC (KeyGEN biotech, Nanjing, China) for 15 min at room
temperature. Then, cell apoptosis was assessed by flow cy-
tometry. Each test was repeated three times.
Statistical analysis
All statistical analyses were performed by using SPSS19.0.
Independent-sample t test was used to compare the difference
between two groups. P<0.05 was considered to be statistically
significant. And the significance level was defined as
*P<0.05, **P<0.01, and ***P<0.001.
Results
LncRNA expression profiles in colorectal cancer
and adenoma tissues
When the adjusted P value was less than 0.01 and the fold
change ≥2 in colorectal cancer tissues compared with adeno-
ma tissues, it will be regarded as differentially expressed
lncRNAs. A total of 135 lncRNAs were found to be signifi-
cantly differentially expressed in colorectal cancer tissues
compared with adenoma tissues. Among them, 71 lncRNAs
were up-regulated and 64 lncRNAs were down-regulated in
colorectal cancer (Supplementary data 2). The top 10 differ-
entially expressed lncRNAs in colorectal cancer tissues were
AK027294, AK001058, AK025818, AK094088, BC137325,
CR749831, AK000106, AB002438, AJ420553, and
AK023519, respectively (Fig. 1a; Table 1). Furthermore, the
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Human CRC cell lines HCT116, HCT8, and SW480 was ac-
quired from the American Type Culture Collection (ATCC)
and cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 5 % fetal bovine serum (FBS)
in a humidified incubator with 5 % CO2 atmosphere at 37 °C.
most differentially expressed lncRNA is AK027294 (fold
change=184.5). Then, we verified the expression of these
lncRNAs in vivo; the colorectal cancer tissues and colorectal
adenoma tissues were obtained from patients and used to
extract RNA to perform RT-PCR. As shown in Fig. 1b, al-
though the expression of AK023519 and BC137325 were
different with the bioinformatics analysis, the expression of
AK027294 was still highest. In addition, according to the
Table 1 More than twofold
differentially expressed lncRNAs
in colorectal cancer tissues
comparing with colorectal
adenoma tissues
Name Log FC P value Relative expression
Colorectal adenoma Colorectal cancer
AK027294 2.266403 3.88E−08 5.008716819 7.275120094
AK001058 1.584973 4.62E−07 6.350289182 7.93526256
AK025818 1.239902 6.08E−06 5.768486904 7.008388975
AK094088 1.016936 0.00017 4.068249686 5.085185471
BC137325 1.008726 1.99E−05 4.868172279 5.876898392
CR749831 −1.11336 0.001701 8.834062854 7.720700755
AK000106 −1.15427 0.000707 7.739382039 6.585108512
AB002438 −1.28354 0.003101 7.104724846 5.821187394
AJ420553 −1.49459 0.000309 7.007212845 5.512623827
AK023519 −2.03528 0.005999 6.863707448 4.828429247
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Fig. 1 The screening of
differentially expressed lncRNAs.
a GSE37364 microarray data
analysis is to identify
differentially expressed lncRNAs
genes. The volcano plot and heat
map shows the differential
lncRNAs expression profiles
between colorectal cancer and
adenoma tissues. Red indicates
high relative expression, and Blue
indicates low relative expression.
b The verification of top 10
differentially expressed lncRNAs






enrichment of signaling pathways, we found that AK027294
was correlated with DNA replication and cycle process in
colorectal cancer (Table 2; Fig. 2), suggesting that
AK027294might play an important role in biological function
of colorectal cancer cells.
AK027294 down-regulation inhibited the proliferation
of colorectal cancer cells
LncRNAmicroarray assay and gene enrichment analysis sug-
gested that AK027294 was involved in cell cycle process and
DNA replication, suggesting that AK027294 might be corre-
lated with cell proliferation and apoptosis. In order to validate
the observations, we knocked down the expression of
AK027294 in HCT116 colorectal cancer cell line by three
specific siRNAs for AK027294. The results were shown in
Fig. 3a, indicating different degrees of reduction in the
AK027294 expression in AK027294 siRNA-transfected cells
(Fig. 3a). CCK-8 assay revealed that when AK027294 expres-
sion was down-regulated, the proliferation of HCT116 cells
was significantly inhibited compared with negative control
siRNA-treated group (Fig. 3b). Furthermore, we also verified
this result in HCT8 and SW480 cells. We found that the pro-
liferation of HCT8 cells (Fig. S1a) and SW480 (Fig. S1b)
treated with these siRNAs was dramatically decreased than
control group. These results were consistent with HCT116
cells’ results, and these results revealed that the down-
Table 2 Potential function of AK027294 was analyzed by enrichment
of signaling pathways
Name Size NES P value
DNA replication 98 2.988205 <0.001
Cell cycle process 189 2.980044 <0.001
Mitotic cell cycle 151 2.929835 <0.001
M-phase of mitotic cell cycle 83 2.90654 <0.001
DNA metabolic process 249 2.899867 <0.001
Cell cycle 310 2.875858 <0.001
Mitosis 80 2.828547 <0.001
Cell cycle phase 166 2.820341 <0.001
M-phase 110 2.812781 <0.001
DNA-dependent replication 54 2.738393 <0.001
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Fig. 2 AK027294 correlated
with DNA replication (a) and cell
cycle process (b) by enrichment
of signaling pathways, the
normalized enrichment score
(NES) for DNA replication and
cell cycle process is 2.988 and
2.980, respectively
regulation of AK027294 was able to inhibit the proliferation
of colorectal cancer cells.
AK027294 down-regulation promoted the apoptosis
of colorectal cancer cell
Then, we evaluated the effects of AK027294 expression on
HCT116 cells’ apoptosis by flow cytometry. As shown in
Fig. 3c, when AK027294 expression was knocked down by
different siRNAs, cell apoptosis rates (8.96–11.14 %) were
markedly increased compared with negative control siRNA-
treated group (2.13 %). To explore the potential mechanism of
AK027294-regulated HCT116 cells’ apoptosis, we detected
the expression of caspase 3, caspase 8, and Bcl-2 by Western
blot. The results revealed that the expression of caspase-3 and
caspase-8 were enhanced in HCT116 cells with the treatment
of AK027294 siRNA compared with control group. In con-
trast, the expression of Bcl-2 was gradually decreased in
HCT116 cells treated with siRNA (Fig. 3d).Moreover, similar
results can be seen in HCT8 cells (Fig. S2a) and SW480 cells
(Fig. S2b). These results indicated that the down-regulation of
AK027294 can promote the apoptosis of colorectal cancer
cells.
AK027294 down-regulation inhibited cell migration
and affected the expression of MMP12, MMP9,
and TWIST1 in HCT116 colorectal cancer cells
In addition, we evaluated the effect of AK027294 on the mi-
gration of HCT116 cells by Wound healing assay and
10102 Tumor Biol. (2016) 37:10097–10105
Fig. 3 AK027294 down-regulation affects HCT116 cells’ proliferation
and apoptosis. a AK027294 expression was detected by qRT-PCR. b
AK027294 down-regulation significantly inhibited cell proliferation by
CCK-8 assay. c AK027294 down-regulation significantly promoted cell
apoptosis by flow cytometry. d AK027294 down-regulation affected the
expression of caspase 3, caspase 8, and BCl-2. **P< 0.01; ***P< 0.001.
NC represents negative control
transwell assay, respectively. In comparison with negative
control siRNA-treated group, wound healing assay exhibited
that the ability of cell migration was significantly inhibited
when the expression of AK027294 was silenced by the three
siRNAs (Fig. 4a). Meanwhile, Transwell assay showed that
when the expression of AK027294 was down-regulated, mi-
grated cells were significantly reduced than those in negative
control siRNA (Fig. 4b). Moreover, in order to explore the
possible mechanism of AK027294 associated with cell migra-
tion, we tested the expression of MMP12 and MMP9 in
HCT116 cells treated by siRNAs by Western blot. The results
demonstrated that AK027294 down-regulation induced the
different degree decrease of MMP12 and MMP9 (Fig. 4c).
Additionally, the expression of MMP12, MMP9 in HCT8
(Fig. S3a), and SW480 (Fig. S3b) cells was declined when
these cells were treated with siRNA. Furthermore, we also
detected the expression of TWIST1 by qRT-PCR andWestern
blot, respectively. Results showed that TWIST1 mRNA and
protein levels were apparently down-regulated when
AK027294 was knocked down by siRNA2 and siRNA3 than
those in control groups (Fig. 4c, d).
Discussion
Recent studies have demonstrated that lncRNAs are linked to
the formation and progression of CRC [13–16]. However,
potential lncRNAs related to both colorectal cancer and colo-
rectal adenoma have not been reported. In this study, we
screened lncRNA expression profiles in colorectal cancer
and adenoma tissues by LncRNA microarray assay. The re-
sults revealed that a total of 135 lncRNAs were differently
expressed in colorectal cancer and adenoma tissues. It is well
known that most colorectal cancers (CRC) arise from colorec-
tal adenomas [17, 18]. Thus, our results revealed that 135
lncRNAs might be potential biomarkers associated with the
formation of CRC. According to the data, we found that 71
and 64 lncRNAs were up-regulated and down-regulated in
colorectal cancer, respectively. Then, we focused on
AK027294 lncRNA, which was found to be correlated with
DNA replication and cycle process in colorectal cancer by the
enrichment of signaling pathways.
AK027294 lncRNA, a novel molecular, was found to be
evidently higher in colorectal cancer than that in colorectal
adenoma. Although enrichment of signaling pathways dem-
onstrated that AK027294 was correlated with DNA replica-
tion and cycle process, its potential functions remained elu-
sive. Thus, we investigated the biological function of
AK027294 in colorectal cancer cells. Results showed that
the down-regulation of AK027294 was able to inhibit prolif-
eration and migration of colorectal cells, and promote apopto-
sis in colorectal cancer. Howerver, the mechanism of
AK027294 was little to be known. It is well known the acti-
vation of caspase 3 and caspase 8 is responsible for cell apo-
ptosis [19, 20]. Bcl-2, an anti-apoptotic gene, is reported to be
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Fig. 4 AK027294 down-
regulation inhibits cell migration.
aAK027294 expression inhibited
cell migration by wound healing
assay. b AK027294 expression
inhibited cell migration by
Transwell assay. cWestern blot
results demonstrated that
AK027294 down-regulation
induced the decrease of MMP12,
MMP9, and TWIST1. d QRT-
PCR results shown that
AK027294 down-regulation
resulted in the decrease of
TWIST1
correlated with cell apoptosis and proliferation [21, 22]. Thus,
we detected the expression of caspase 3, caspase 8, and BCL-2,
when AK027294 expression was significantly knocked down in
colorectal cancer cells. The current results revealed that down-
regulation of AK027294 in colorectal cells induced the increase
of caspase 3 and caspase 8 expression but resulted in the de-
crease of BCL-2 expression in colorectal cancer cells, indicating
that AK027294 affected cell apoptosis and proliferation via reg-
ulating the expression of caspase 3, caspase 8, and Bcl-2. In
addition, it is well known that both MMP9 and MMP12 are
involved in the process of cell migration [23, 24]. TWIST1 is
frequently reported to be highly expressed in colorectal cancer
and is correlated with tumor formation and progression [25, 26].
While the relationships between AK027294 and MMP9,
MMP12, and TWIST1 in cell migration remain unknown.
Thus, we detected the expression of MMP9, MMP12, and
TWIST1 in colorectal cancer cells. The results showed that
MMP9, MMP12, and TWIST1 were down-regulated when
AK027294 expression in colorectal cells was knocked down.
These results indicated that the effect of AK027294 down-
regulation on cell migration was correlated with MMP9,
MMP12, and TWIST1.
Conclusions
In summary, we screen a lncRNA expression profile associat-
ed with colorectal cancer and colorectal adenoma. AK027294
is confirmed to be a novel lncRNA, which is correlated with
cell proliferation, migration, and apoptosis in colorectal cancer
cells. Our findings suggest that AK027294 may play an im-
portant role in colorectal occurrence and progression and may
be a potential target to prevent progression of colorectal can-
cer. As this study is the first to report the biological functions
of AK027294, further detailed and in-depth investigations are
needed to validate our observations.
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